Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
5.08
+0.18 (3.67%)
Jan 22, 2026, 4:00 PM EST - Market closed
Evolus Market Cap
Evolus has a market cap or net worth of $329.28 million as of January 22, 2026. Its market cap has decreased by -52.73% in one year.
Market Cap
329.28M
Enterprise Value
440.65M
1-Year Change
-52.73%
Ranking
Category
Stock Price
$5.08
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.32M to $329.28M, an increase of 21.36%. That is a compound annual growth rate of 2.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 329.28M | -23.61% |
| Dec 31, 2025 | 431.05M | -38.34% |
| Dec 31, 2024 | 699.07M | 14.94% |
| Dec 29, 2023 | 608.22M | 43.99% |
| Dec 30, 2022 | 422.41M | 16.75% |
| Dec 31, 2021 | 361.81M | 219.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Organogenesis Holdings | 509.55M |
| SIGA Technologies | 481.94M |
| Kamada | 460.35M |
| Canopy Growth | 429.59M |
| Eton Pharmaceuticals | 409.50M |
| Aquestive Therapeutics | 396.51M |
| Akebia Therapeutics | 382.13M |
| Lifecore Biomedical | 321.46M |